APA (7th ed.) Citation

Barbour, M., Wood, R., Hridi, S. U., Wilson, C., McKay, G., Bushell, T. J., & Jiang, H. (2018). The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels. Journal of Neuroimmunology, 318, 87. https://doi.org/10.1016/j.jneuroim.2018.02.012

Chicago Style (17th ed.) Citation

Barbour, Mark, Rachel Wood, Shehla U. Hridi, Chelsey Wilson, Grant McKay, Trevor J. Bushell, and Hui-Rong Jiang. "The Therapeutic Effect of Anti-CD52 Treatment in Murine Experimental Autoimmune Encephalomyelitis Is Associated with Altered IL-33 and ST2 Expression Levels." Journal of Neuroimmunology 318 (2018): 87. https://doi.org/10.1016/j.jneuroim.2018.02.012.

MLA (9th ed.) Citation

Barbour, Mark, et al. "The Therapeutic Effect of Anti-CD52 Treatment in Murine Experimental Autoimmune Encephalomyelitis Is Associated with Altered IL-33 and ST2 Expression Levels." Journal of Neuroimmunology, vol. 318, 2018, p. 87, https://doi.org/10.1016/j.jneuroim.2018.02.012.